Integumentary care



Integumentary care






Diseases


Acne vulgaris

Acne vulgaris is an inflammatory disease of the skin glands and hair follicles that appears as comedones, pustules, nodules, and nodular lesions. This disorder, which tends to run in families, affects nearly 85% of adolescents with a westernized lifestyle, although lesions can appear as early as age 8. Acne affects boys more commonly and more severely; however, it typically occurs in girls at an earlier age and tends to affect them for a longer time, sometimes into adulthood. With treatment, the prognosis is good.




Signs and symptoms



  • Pain and tenderness around the area of the infected follicle


  • Acne lesions, most commonly on the face, neck, shoulders, chest, and upper back


  • Area around the infected follicle that appears red and swollen


  • Acne plug that may appear as a closed comedo, or whitehead (if it doesn’t protrude from the follicle and is covered by the epidermis), or as an open comedo, or blackhead (if it protrudes and isn’t covered by the epidermis)


  • Inflammation and characteristic acne pustules, papules or, in severe forms, acne cysts or abscesses


  • Visible scars


Treatment



  • Benzoyl peroxide (powerful antibacterial)


  • Clindamycin (Cleocin), erythromycin (Akne-mycin), or antibacterial agents alone or in combination with tretinoin (retinoic acid [Retin-A] or topical vitamin A)


  • Tetracycline to decrease bacterial growth


  • Oral isotretinoin (Amnesteem)


  • Birth control pills (such as Ortho-TriCyclen) or spironolactone to produce antiandrogenic effects (in females)


  • Intralesional corticosteroid injections


  • Exposure to ultraviolet light (but never when a photosensitizing agent, such as isotretinoin, is being used)


  • Cryotherapy


  • Acne surgery




Nursing considerations



  • Assist the patient in identifying and eliminating predisposing factors.


  • Encourage good personal hygiene and the use of oil-free skin care products. Discourage picking, scratching, or squeezing the lesions to eliminate secondary bacterial infections and scarring.


  • Monitor liver function studies and serum triglyceride levels when isotretinoin is used.


  • Be alert for possible complications associated with using systemic antibiotics (such as tetracycline), including sensitivity reactions, GI disturbances, and liver dysfunction.


  • Remember that tetracycline is contraindicated during pregnancy because it discolors the fetus’s unerupted teeth.


  • Be alert for possible adverse reactions associated with using isotretinoin, including possible skin irritation, dry skin and mucous membranes, and elevated triglyceride levels.


  • Encourage the patient with acne to verbalize his feelings, including embarrassment, fear of rejection by others, and disturbed body image. Note the importance of body image in growth and development. Encourage him to develop interests that support a positive self-image and deemphasize appearance.




Basal cell carcinoma

Basal cell carcinoma, also known as basal cell epithelioma, is a slow-growing, destructive skin tumor that usually occurs in people older than age 40. Forty to fifty percent of Americans age 65 or older will have either basal cell or squamous cell carcinoma at least once during their lifetime. It’s most prevalent in blond, fair-skinned males, and it’s the most common malignant tumor that affects whites. The two major types of basal cell carcinoma are noduloulcerative and superficial.

Prolonged sun exposure is the most common cause of basal cell carcinoma. Indeed, 90% of tumors occur on sun-exposed areas of the body. Arsenic ingestion, radiation exposure (including tanning beds), burns, immunosuppression and, rarely, vaccinations are other possible causes.

Although the pathogenesis is uncertain, some experts hypothesize that basal cell carcinoma develops when undifferentiated basal cells become carcinomatous instead of differentiating into sweat glands, sebum, and hair.


Signs and symptoms



  • Lesions that appear as small, smooth, pinkish, and translucent papules (early-stage noduloulcerative), particularly on the forehead, eyelid margins, and nasolabial folds


  • Telangiectatic vessels crossing the surface


  • Lesions that may be pigmented


  • As lesions enlarge, centers that become depressed and borders that become firm and elevated (rodent ulcers)


  • Multiple oval or irregularly shaped, lightly pigmented plaques that may have sharply defined, slightly elevated, threadlike borders (superficial basal cell carcinomas)

Inspection of the head and neck may show waxy, sclerotic, yellow to white plaques without distinct borders. These plaques may resemble small patches of scleroderma and may suggest sclerosing basal cell carcinomas (morphea-like carcinomas).




Treatment



  • Curettage and electrodesiccation for small lesions


  • Topical fluorouracil for superficial lesions; produces marked local irritation or inflammation in the involved tissue but no systemic effects


  • Microscopically controlled surgical excision to remove recurrent lesions until a tumor-free plane is achieved; possible skin grafting after removal of large lesions


  • Irradiation, if the tumor location requires it and for elderly or debilitated patients who might not tolerate surgery


  • Chemosurgery for persistent or recurrent lesions; consists of periodic applications of a fixative paste (such as zinc chloride) and subsequent removal of fixed pathologic tissue until the tumor is eradicated


  • Cryotherapy, using liquid nitrogen, to freeze and, ultimately, kill cells


Nursing considerations



  • Listen to the patient’s fears and concerns. Offer reassurance, when appropriate. Remain with the patient during periods of severe stress and anxiety. Provide positive reinforcement for the patient’s efforts to adapt.


  • Arrange for the patient to interact with others who have a similar problem.


  • Assess the patient’s readiness for decision making; then involve him and family members in decisions related to his care whenever possible.


  • Watch for complications of treatment, including local skin irritation from topically applied chemotherapeutic agents and infection.


  • Watch for radiation’s adverse effects, such as nausea, vomiting, hair loss, malaise, and diarrhea. Provide reassurance and comfort measures, when appropriate.




Burns

A major burn is a devastating injury, requiring painful treatment and a long period of rehabilitation. Burns can be fatal, permanently disfiguring, and incapacitating, both emotionally and physically.

Thermal burns, the most common type, typically result from residential fires, motor vehicle accidents, misused matches or lighters (such as a child playing with matches), improperly stored gasoline, space heater or electrical malfunctions, and arson. Other causes include improper handling of firecrackers, scalding accidents, and kitchen accidents (such as a child touching a hot stove).

Chemical burns result from the contact, ingestion, inhalation, or injection of acids, alkali, or vesicants. Electrical burns commonly occur after contact with faulty electrical wiring or high-voltage power lines, or when electric cords are chewed (by young children).

Radiation burns are caused by ionizing radiation and include sunburn and radiotherapy burns. Friction, or abrasion, burns happen when the skin is rubbed harshly against a coarse surface.

Burn severity is classified by depth of injury.


Superficial burns

Superficial burns, also referred to as first-degree burns, cause localized injury to the skin (epidermis only) by direct (such as a chemical spill) or indirect (such as sunlight) contact. The barrier function of the skin remains intact, and these burns aren’t life-threatening.


Superficial partial-thickness burns

Superficial partial-thickness burns, also referred to as second-degree burns, involve destruction to the epidermis and some dermis. Thin-walled, fluid-filled blisters develop within a few minutes of the injury along with mild to moderate edema and pain. As these blisters break, the nerve endings become exposed to the air. Because pain and tactile response remains intact, subsequent treatments are very painful. The barrier function of the skin is lost.


Deep partial-thickness burns

Deep partial-thickness burns are a more severe second-degree burn that extends deeper into the dermis. The skin appears mixed red or waxy white. Blisters aren’t usually present and edema usually develops. Sensation is decreased in the area of the burn.





Full-thickness burns

Full-thickness burns, also referred to as third-degree burns, affect every body system and organ. A full-thickness burn extends through the epidermis and dermis into the subcutaneous tissue. Within hours, fluid and protein shift from capillary to interstitial spaces, causing edema. The immediate immunologic response to the burn injury makes burn wound sepsis a potential threat. Last, an increased calorie demand after the burn injury increases the metabolic rate.


Fourth-degree burns

Fourth-degree burns involve muscle, bone, and interstitial tissues.



Signs and symptoms


Superficial burn



  • Localized pain and erythema, usually without blisters in the first 24 hours, caused by injury from direct or indirect contact with a burn source


  • Chills, headache, localized edema, and nausea and vomiting (in more severe cases)


Superficial partial-thickness burn



  • Thin-walled, fluid-filled blisters appearing within minutes of the injury, with mild to moderate edema and pain


Deep partial-thickness burn



  • White, waxy or mixed red appearance to the damaged area


  • Decreased capillary refill and sensation


Full-thickness burn



  • White, brown, or black leathery tissue and visible thrombosed vessels due to destruction of skin elasticity (dorsum of the hand is the most common site of thrombosed veins), without blisters


Fourth-degree burn



  • Damage extends through deeply charred subcutaneous tissue to muscle and bone


  • Usually painless because nerve fibers are burned


Treatment



  • Immediate classification and estimation of extent or injury to guide treatment


  • Lactated Ringer’s solution through a large-bore I.V. line to expand vascular volume; volume of infusion calculated according to the extent of the area burned and the time that has elapsed since the burn injury occurred


  • Indwelling urinary catheter to permit accurate monitoring of urine output


  • I.V. morphine to alleviate pain and anxiety


  • Nasogastric (NG) tube to prevent gastric distention and accompanying ileus from hypovolemic shock


  • Booster of 0.5 ml of tetanus toxoid administered I.M.


Treatment of the burn wound



  • Initial debriding by washing the surface of the wound area with mild soap


  • Sharp debridement of loose tissue and blisters (blister fluid contains agents that reduce bactericidal activity and increase inflammatory response)


  • Partial-thickness wounds: covering with hydrogel, silicone-coated nylon, or other dressing


  • Fourth-degree wounds: covering the wound with an antimicrobial and a nonstick bulky dressing (after debridement)


  • Escharotomy, if the patient is at risk for vascular, circulatory, or respiratory compromise



Nursing considerations



  • For severe burns, provide immediate, aggressive treatment to increase the patient’s chance for survival. Make sure the patient with major or moderate burns has adequate airway, breathing, and circulation. If needed, assist with endotracheal intubation. Administer 100% oxygen, as ordered, and adjust the flow to maintain adequate gas exchange.


  • Provide sufficient I.V. fluids to maintain a urine output of 30 to 50 ml/hour; the output of a child who weighs less than 66 lb (29.9 kg) should be maintained at 1 ml/kg/hour.


  • Remove any clothing that’s still smoldering. If it continues to adhere to the patient’s skin, first soak it in saline solution. Also remove jewelry and other constricting items.


  • Cover the burns with a clean, dry, sterile bed sheet.


  • Never cover large burns with saline-soaked dressings, which can drastically lower body temperature.


  • Start I.V. therapy immediately to prevent hypovolemic shock and maintain cardiac output. Use lactated Ringer’s solution or a fluid replacement formula, as ordered. Closely monitor the patient’s intake and output.


  • Assist with the insertion of a central venous pressure line and additional arterial and I.V. lines (using venous cutdown, if necessary), as needed. Insert an indwelling urinary catheter as ordered.


  • Continue fluid therapy, as ordered, to combat fluid evaporation through the burn and the release of fluid into interstitial spaces (possibly resulting in hypovolemic shock).


  • Check the patient’s vital signs every 15 minutes. Maintain his core body temperature by covering him with a sterile blanket and exposing only small areas of his body at a time.


  • Monitor the patient for signs and symptoms of shock—altered level of consciousness, hypotension, and respiratory distress.


  • Insert an NG tube, as ordered, to decompress the stomach and avoid aspiration of stomach contents.


  • Provide a diet high in potassium, protein, vitamins, fats, nitrogen, and calories to keep the patient’s weight as close to his preburn weight as possible. If necessary, feed the patient through a feeding tube (as soon as bowel sounds return, if he has had paralytic ileus) until he can tolerate oral feeding. Weigh him every day at the same time.


  • If the patient is to be transferred to a specialized burn care unit, prepare the patient for transport by wrapping him in a sterile sheet and a blanket for warmth and elevating the burned extremity to decrease edema.


  • If the patient has only minor burns, immerse the burned area in cool saline solution (55° F [12.8° C]) or apply cool compresses, making sure he doesn’t develop hypothermia. Next, soak the wound in a mild antiseptic solution to clean it, and give ordered pain medication.


  • Debride the devitalized tissue. Cover the wound with an antibacterial agent and a nonstick bulky dressing, and administer tetanus prophylaxis, as ordered.


  • Explain all procedures to the patient before performing them. Speak calmly and clearly to help alleviate his anxiety.


  • Give the patient opportunities to voice his concerns, especially about altered body image. When possible, show the patient how his bodily functions are improving. If necessary, refer him for mental health counseling.


  • Administer pain medication as ordered and evaluate its effectiveness. Provide emotional support because burns can be very painful as well as disfiguring.




Cellulitis

An infection of the dermis or subcutaneous layer of the skin, cellulitis may follow damage to the skin, such as with a bite or a wound. If treated in a timely manner, the prognosis is usually good. If the cellulitis spreads, however, fever, erythema, and lymphangitis may occur, particularly in patients with other contributing health factors, such as diabetes, immunodeficiency, impaired circulation, or neuropathy.





Signs and symptoms



  • Erythema and edema


  • Pain at the site and, possibly, the surrounding area


  • Fever and warmth


Treatment



  • Antibiotics, either p.o. or I.V., for the causative organism, depending on the severity


  • Pain medication, as needed, to promote comfort


  • Elevation of the affected extremity above heart level to promote comfort and decrease edema


  • Modified bed rest


Nursing considerations



  • Assess the patient for an increase in size of the affected area or worsening pain.


  • Administer an antibiotic and an analgesic, and elevate the extremity as ordered.




Dermatitis

Dermatitis is characterized by inflammation of the skin and may be acute or chronic. It occurs in several forms, including contact, seborrheic, nummular, exfoliative, and stasis dermatitis.

Atopic dermatitis (discussed here), also commonly referred to as atopic or infantile eczema or Besnier’s prurigo, is a chronic inflammatory response typically associated with other atopic diseases, such as bronchial asthma, allergic rhinitis, and chronic urticaria. It usually develops in infants and toddlers between ages 6 months and 2 years, commonly in those with strong family histories of atopic disease. These children typically acquire other atopic disorders as they grow older. In most cases, this form of dermatitis subsides spontaneously by age 3 and remains in remission until prepuberty (ages 10 to 12), when it flares up again. The disorder affects about 9 out of every 1,000 people.

Atopic dermatitis is exacerbated by certain irritants, infections (commonly Staphylococcus aureus), and allergens. Common allergens include pollen, wool, silk, fur, ointment, detergent, perfume, and certain foods, particularly wheat, milk, and eggs. Flare-ups may also occur in response to temperature extremes, humidity, sweating, and stress.





Signs and symptoms



  • Intense itching


  • Erythematous patches in excessively dry areas at flexion points, such as the antecubital fossa, popliteal area, and neck; in children, may appear on the forehead, cheeks, and extensor surfaces of the arms and legs


  • Edema, scaling, and vesiculation because of scratching


  • Vesicles that may be pus-filled


  • With chronic disease, multiple areas of dry, scaly skin with white dermatographism, blanching, and lichenification




Treatment



  • Eliminating allergens and avoiding irritants, extreme temperature changes, and other precipitating factors


  • Systemic antihistamines, such as hydroxyzine hydrochloride and diphenhydramine, to relieve pruritus


  • Topical application of a corticosteroid cream to alleviate inflammation


  • Systemic corticosteroid therapy only during extreme exacerbations


  • Weak tar preparations and ultraviolet B light therapy to increase the thickness of the stratum corneum


  • Antibiotics to fight a bacterial infection; antifungals or antivirals to fight a fungal or viral infection




Nursing considerations



  • Help the patient schedule daily skin care. Keep his fingernails short to limit excoriation and secondary infections caused by scratching.


  • Be alert for possible adverse effects associated with corticosteroid use: sensitivity reactions, GI disturbances, musculoskeletal weakness, neurologic disturbances, and cushingoid symptoms.


  • To help clear lichenified skin, apply occlusive dressings, such as a plastic film, intermittently. This treatment requires a physician’s order and experience in dermatologic treatment.


  • Apply cool, moist compresses to relieve itching and burning.


  • Encourage the patient to verbalize feelings about his appearance, including embarrassment and fear of rejection. Offer him emotional support and reassurance and arrange for counseling, if necessary.




Herpes zoster

Herpes zoster, also called shingles, is an acute, unilateral and segmental inflammation of the dorsal root ganglia and is caused by the varicella-zoster virus (herpesvirus). It produces localized vesicular skin lesions confined to a dermatome, which may produce severe neuralgic pain in the areas bordering the inflamed nerve root ganglia.

The infection is found primarily in adults ages 50 to 70, and the prognosis is usually good, with most patients recovering completely, unless the infection spreads to the brain.

Herpes zoster is more severe in the immunocompromised patient but seldom is fatal. Patients who have received a bone marrow transplant are especially at risk for the infection.

Although the process is unclear, the disease seems to erupt when the virus reactivates after dormancy in the cerebral ganglia (extramedullary ganglia of the cranial nerves) or the ganglia of posterior nerve roots. The virus then may multiply as it reactivates, but antibodies remaining from the initial infection may neutralize it. Without opposition, however, the virus continues to multiply in the ganglia, destroys neurons, and spreads down the sensory nerves to the skin.

Herpes zoster is contagious until all the blisters are crusted over, but only for individuals who haven’t previously had chickenpox.




Signs and symptoms



  • Fever


  • Malaise


  • Burning or sensitive skin several days before rash appears


  • Pain that mimics appendicitis, pleurisy, musculoskeletal pain, or other conditions


  • After 2 to 4 days, severe, deep pain; pruritus; and paresthesia or hyperesthesia (usually affecting the trunk and, occasionally, the arms and legs)


  • Pain that may be intermittent, continuous, or debilitating, usually lasting from 1 to 4 weeks


  • Fluid-filled vesicles with an erythematous base on skin areas supplied by sensory nerves of a single or associated group of dorsal root ganglia (nerve pathways)


  • After about 10 days, dried vesicles that have formed scabs


  • Enlarged regional lymph nodes


  • With geniculate involvement, vesicles in the external auditory canal, ipsilateral facial palsy, hearing loss, dizziness, and loss of taste


  • With trigeminal involvement, eye pain, possible corneal and scleral damage, and impaired vision




Treatment



  • Oral acyclovir (Zovirax), famciclovir (Famvir), and valacyclovir (Valtrex) therapy to accelerate healing of lesions and resolution of zoster-associated pain


  • Antipruritics (such as calamine lotion) to relieve pruritus and analgesics (such as aspirin, acetaminophen or, possibly, codeine) to relieve neuralgic pain


  • Tricyclic antidepressants to help relieve neuritic pain


  • Systemic corticosteroids, such as cortisone or corticotropin, to reduce inflammation and the intractable pain of postherpetic neuralgia (other possible therapies: tranquilizers, sedatives, or tricyclic antidepressants with phenothiazines)


  • As a last resort for pain relief, transcutaneous peripheral nerve stimulation, patient-controlled analgesia, or a small dose of radiotherapy


  • Cool compresses and use of Burow’s or Domeboro solution


Nursing considerations

Jun 5, 2016 | Posted by in NURSING | Comments Off on Integumentary care

Full access? Get Clinical Tree

Get Clinical Tree app for offline access